{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:58:44Z","timestamp":1791921524161,"version":"4.3.4"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007631","name":"Canadian Institute for Advanced Research","doi-asserted-by":"publisher","award":["Azrieli Global Fellowship"],"award-info":[{"award-number":["Azrieli Global Fellowship"]}],"id":[{"id":"10.13039\/100007631","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Engineering Research Council","award":["CREATE"],"award-info":[{"award-number":["CREATE"]}]},{"DOI":"10.13039\/100010318","name":"University of Manitoba","doi-asserted-by":"publisher","award":["Faculty of Science Graduate Enhancement of Grant Stipends (SEGS)"],"award-info":[{"award-number":["Faculty of Science Graduate Enhancement of Grant Stipends (SEGS)"]}],"id":[{"id":"10.13039\/100010318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1011684","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T18:34:33Z","timestamp":1699641273000},"page":"e1011684","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Insights and advances in recurrent vulvovaginal candidiasis"],"prefix":"10.1371","volume":"19","author":[{"given":"Javier","family":"San Juan Gal\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Poliquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0781-9356","authenticated-orcid":true,"given":"Aleeza Cara","family":"Gerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"ppat.1011684.ref001","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis.","volume":"369","author":"JD Sobel","year":"2007","journal-title":"Lancet"},{"key":"ppat.1011684.ref002","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","article-title":"Global burden of recurrent vulvovaginal candidiasis: a systematic review","volume":"18","author":"DW Denning","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ppat.1011684.ref003","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1472-6874-14-43","article-title":"Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented.","volume":"14","author":"SD Rathod","year":"2014","journal-title":"BMC Womens Health"},{"key":"ppat.1011684.ref004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1477-7525-11-169","article-title":"Subjective health status and health-related quality of life among women with recurrent vulvovaginal candidosis (RVVC) in Europe and the USA.","volume":"11","author":"S Aball\u00e9a","year":"2013","journal-title":"Health Qual Life Outcomes."},{"key":"ppat.1011684.ref005","doi-asserted-by":"crossref","first-page":"934353","DOI":"10.3389\/fcimb.2022.934353","article-title":"Management of recurrent vulvovaginal candidosis: narrative review of the literature and European expert panel opinion","volume":"12","author":"G Donders","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"ppat.1011684.ref006","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajog.2015.06.067","article-title":"Recurrent vulvovaginal candidiasis.","volume":"214","author":"JD Sobel","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"ppat.1011684.ref007","doi-asserted-by":"crossref","first-page":"e54379","DOI":"10.1371\/journal.pone.0054379","article-title":"Characterization of the vaginal micro- and mycobiome in asymptomatic reproductive-age Estonian women.","volume":"8","author":"T Drell","year":"2013","journal-title":"PLoS ONE."},{"key":"ppat.1011684.ref008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-6515-1_1","volume-title":"Human fungal pathogen identification: methods and protocols","author":"C. Lass-Fl\u00f6rl","year":"2017"},{"key":"ppat.1011684.ref009","first-page":"59","article-title":"Name changes for fungi of medical importance, 2018 to 2019","volume":"2021","author":"AM Borman","year":"2018","journal-title":"J Clin Microbiol"},{"key":"ppat.1011684.ref010","first-page":"3","article-title":"New names for fungi of medical importance: can we have our cake and eat it too?","volume":"59","author":"SE Kidd","year":"2021","journal-title":"J Clin Microbiol"},{"key":"ppat.1011684.ref011","article-title":"Fungal nomenclature: managing change is the name of the game","volume":"10","author":"SE Kidd","year":"2023","journal-title":"Open Forum. Infect Dis Ther"},{"key":"ppat.1011684.ref012","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11908-010-0137-9","article-title":"Vulvovaginal candidiasis caused by non-albicans Candida species: new insights.","volume":"12","author":"MA Kennedy","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"ppat.1011684.ref013","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1055\/a-1345-8793","article-title":"Vulvovaginal candidosis (excluding mucocutaneous candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) society of Gynecology and Obstetrics (S2k-level, AWMF registry number 015\/072, September 2020).","volume":"81","author":"A Farr","year":"2021","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ppat.1011684.ref014","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1701-2163(15)30316-9","article-title":"Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis","volume":"37","author":"J van Schalkwyk","year":"2015","journal-title":"J Obstet Gynaecol Can."},{"issue":"8","key":"ppat.1011684.ref015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1258\/ijsa.2011.011012","article-title":"European (IUSTI\/WHO) guideline on the management of vaginal discharge, 2011","volume":"22","author":"J Sherrard","year":"2011","journal-title":"Int J STD AIDS"},{"issue":"2","key":"ppat.1011684.ref016","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13693780601059936","article-title":"Yeast identification\u2014past, present, and future methods","volume":"45","author":"DH Pincus","year":"2007","journal-title":"Med Mycol"},{"issue":"8","key":"ppat.1011684.ref017","doi-asserted-by":"crossref","first-page":"e0202401","DOI":"10.1371\/journal.pone.0202401","article-title":"Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: a non-targeted LC-MS pilot study.","volume":"13","author":"JM Sanches","year":"2018","journal-title":"PLoS ONE"},{"key":"ppat.1011684.ref018","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s10096-021-04199-1","article-title":"Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence","volume":"40","author":"LC Pereira","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ppat.1011684.ref019","first-page":"58","article-title":"Clinical validation of the Aptima Bacterial Vaginosis and Aptima Candida\/Trichomonas Vaginitis assays: results from a prospective multicenter clinical study","author":"JR Schwebke","year":"2020","journal-title":"J Clin Microbiol"},{"key":"ppat.1011684.ref020","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1038\/s41467-018-04787-4","article-title":"Gene flow contributes to diversification of the major fungal pathogen Candida albicans","volume":"9","author":"J Ropars","year":"2018","journal-title":"Nat Commun"},{"key":"ppat.1011684.ref021","doi-asserted-by":"crossref","first-page":"e0010723","DOI":"10.1128\/mbio.00107-23","article-title":"A new phenotype in Candida-epithelial cell interaction distinguishes colonization- versus vulvovaginal candidiasis-associated strains","author":"A Sala","year":"2023","journal-title":"MBio"},{"key":"ppat.1011684.ref022","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1128\/IAI.72.5.2939-2946.2004","article-title":"An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis","volume":"72","author":"PL Fidel","year":"2004","journal-title":"Infect Immun"},{"key":"ppat.1011684.ref023","doi-asserted-by":"crossref","first-page":"17877","DOI":"10.1038\/s41598-017-17649-8","article-title":"NLRP3 inflammasome is a key player in human vulvovaginal disease caused by Candida albicans.","volume":"7","author":"E Roselletti","year":"2017","journal-title":"Sci Rep"},{"key":"ppat.1011684.ref024","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1056\/NEJMoa0901053","article-title":"Human dectin-1 deficiency and mucocutaneous fungal infections","volume":"361","author":"B Ferwerda","year":"2009","journal-title":"N Engl J Med"},{"key":"ppat.1011684.ref025","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3389\/fmicb.2018.02434","article-title":"Frequency and geographic distribution of CARD9 mutations in patients with severe fungal infections.","volume":"9","author":"A Vaezi","year":"2018","journal-title":"Front Microbiol."},{"key":"ppat.1011684.ref026","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.mehy.2013.08.015","article-title":"Unique variation in genetic selection among Black North American women and its potential influence on pregnancy outcome.","volume":"81","author":"S Jaffe","year":"2013","journal-title":"Med Hypotheses"},{"key":"ppat.1011684.ref027","doi-asserted-by":"crossref","first-page":"e0062221","DOI":"10.1128\/mSystems.00622-21","article-title":"Recurrent vulvovaginal candidiasis: a dynamic interkingdom biofilm disease of Candida and Lactobacillus.","volume":"6","author":"E McKloud","year":"2021","journal-title":"mSystems."},{"key":"ppat.1011684.ref028","first-page":"45","article-title":"The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives","author":"C d\u2019Enfert","year":"2021","journal-title":"FEMS Microbiol Rev"},{"key":"ppat.1011684.ref029","doi-asserted-by":"crossref","first-page":"e0158870","DOI":"10.1371\/journal.pone.0158870","article-title":"Highlights regarding host predisposing factors to recurrent vulvovaginal candidiasis: chronic stress and reduced antioxidant capacity.","volume":"11","author":"L Akimoto-Gunther","year":"2016","journal-title":"PLoS ONE"},{"key":"ppat.1011684.ref030","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1128\/IAI.00436-09","article-title":"Vaginal microbiota of women with frequent vulvovaginal candidiasis","volume":"77","author":"X Zhou","year":"2009","journal-title":"Infect Immun"},{"key":"ppat.1011684.ref031","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3109\/1040841X.2015.1091805","article-title":"Vulvovaginal candidiasis: epidemiology, microbiology and risk factors","volume":"42","author":"B Gon\u00e7alves","year":"2016","journal-title":"Crit Rev Microbiol"},{"key":"ppat.1011684.ref032","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcf.2017.07.017","article-title":"Sexual and reproductive health behaviors and experiences reported by young women with cystic fibrosis.","volume":"17","author":"TM Kazmerski","year":"2018","journal-title":"J Cyst Fibros"},{"key":"ppat.1011684.ref033","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/LGT.0000000000000641","article-title":"Mixed vaginitis due to bacterial vaginosis and candidiasis.","volume":"26","author":"D Benyas","year":"2022","journal-title":"J Low Genit Tract Dis"},{"key":"ppat.1011684.ref034","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/jdi.12912","article-title":"Incidence and risk of vaginal candidiasis associated with sodium-glucose cotransporter 2 inhibitors in real-world practice for women with type 2 diabetes","volume":"10","author":"H Yokoyama","year":"2019","journal-title":"J Diabetes Investig"},{"key":"ppat.1011684.ref035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/LGT.0b013e3182241f1a","article-title":"Vulvovaginal candidiasis in postmenopausal women: the role of hormone replacement therapy.","volume":"15","author":"G Fischer","year":"2011","journal-title":"J Low Genit Tract Dis"},{"key":"ppat.1011684.ref036","doi-asserted-by":"crossref","first-page":"105055","DOI":"10.1016\/j.micpath.2021.105055","article-title":"Characterization of vaginal fungal communities in healthy women and women with bacterial vaginosis (BV); a pilot study.","volume":"161","author":"L Lehtoranta","year":"2021","journal-title":"Microb Pathog"},{"key":"ppat.1011684.ref037","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2165\/00003495-200363110-00002","article-title":"Management of patients with recurrent vulvovaginal candidiasis.","volume":"63","author":"JD Sobel","year":"2003","journal-title":"Drugs."},{"issue":"5","key":"ppat.1011684.ref038","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/cid\/ciad002","article-title":"New antifungals for vulvovaginal candidiasis: what is their role?","volume":"76","author":"JD Sobel","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ppat.1011684.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"PG Pappas","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ppat.1011684.ref040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9378(16)32581-9","article-title":"Treatment of vulvovaginal candidiasis with boric acid powder.","volume":"141","author":"KK Van Slyke","year":"1981","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"ppat.1011684.ref041","doi-asserted-by":"crossref","first-page":"e0240621","DOI":"10.1128\/aac.02406-21","article-title":"Differential response of Candida species morphologies and isolates to fluconazole and boric acid","volume":"66","author":"OE Salama","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"ppat.1011684.ref042","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00204-020-02700-x","article-title":"Effects of boron compounds on human reproduction","volume":"94","author":"HM Bolt","year":"2020","journal-title":"Arch Toxicol"},{"issue":"1","key":"ppat.1011684.ref043","first-page":"38","article-title":"Topical treatment of recurrent vulvovaginal candidiasis: an expert consensus.","volume":"3","author":"NA Phillips","year":"2022","journal-title":"Womens Health Rep (New Rochelle)."},{"issue":"9","key":"ppat.1011684.ref044","article-title":"Compliance with the updated BASHH recurrent vulvovaginal candidiasis guidelines improves patient outcomes.","volume":"8","author":"L Brown","year":"2022","journal-title":"J Fungi (Basel)."},{"key":"ppat.1011684.ref045","doi-asserted-by":"crossref","first-page":"e12970","DOI":"10.1111\/dth.12970","article-title":"Probiotics for oral and vulvovaginal candidiasis: a review.","volume":"32","author":"A Shenoy","year":"2019","journal-title":"Dermatol Ther."},{"key":"ppat.1011684.ref046","unstructured":"Center for Drug Evaluation, Research. Novel Drug Approvals for 2022. In: U.S. Food and Drug Administration [Internet]. FDA; [cited 28 May 2023]. Available from: https:\/\/www.fda.gov\/drugs\/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products\/novel-drug-approvals-2022."},{"issue":"18","key":"ppat.1011684.ref047","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2217\/fmb-2021-0173","article-title":"Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis.","volume":"16","author":"JD Sobel","year":"2021","journal-title":"Future Microbiol"},{"key":"ppat.1011684.ref048","first-page":"63","article-title":"In vitro activities of the novel investigational tetrazoles VT-1161 and VT-1598 compared to the triazole antifungals against azole-resistant strains and clinical isolates of Candida albicans","author":"AT Nishimoto","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ppat.1011684.ref049","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2022.07.023","article-title":"Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections.","volume":"227","author":"MG Martens","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"ppat.1011684.ref050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/EVIDoa2100055","article-title":"Efficacy and safety of oteseconazole in recurrent vulvovaginal candidiasis.","volume":"1","author":"JD Sobel","year":"2022","journal-title":"NEJM Evidence."},{"issue":"23","key":"ppat.1011684.ref051","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/ajhp\/zxac247","article-title":"Oteseconazole","volume":"79","year":"2022","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"ppat.1011684.ref052","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/jwh.2022.0132","article-title":"Oral ibrexafungerp for vulvovaginal candidiasis treatment: an analysis of VANISH 303 and VANISH 306.","volume":"32","author":"O Goje","year":"2023","journal-title":"J Womens Health"},{"key":"ppat.1011684.ref053","doi-asserted-by":"crossref","first-page":"906563","DOI":"10.3389\/fcimb.2022.906563","article-title":"In vitro antifungal activity of ibrexafungerp (SCY-078) against contemporary blood isolates from medically relevant species of Candida: a European study.","volume":"12","author":"G Quind\u00f3s","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"ppat.1011684.ref054","doi-asserted-by":"crossref","first-page":"S771","DOI":"10.1016\/j.ajog.2022.11.106","article-title":"A phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of once monthly oral ibrexafungerp for prevention of recurrent vulvovaginal candidiasis (VVC).","volume":"228","author":"O Goje","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"ppat.1011684.ref055","article-title":"Ibrexafungerp: A first-in-class oral triterpenoid glucan synthase inhibitor.","volume":"7","author":"S Jallow","year":"2021","journal-title":"J Fungi (Basel)."},{"issue":"12","key":"ppat.1011684.ref056","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis-a Phase 2 randomized, double-blind, placebo-controlled trial.","volume":"66","author":"JE Edwards","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1011684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T18:35:01Z","timestamp":1699641301000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1011684"}},"subtitle":[],"editor":[{"given":"Mary Ann","family":"Jabra-Rizk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":56,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1011684","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]}}}